On-Demand Webinars

[On-Demand Webinar] Biosimilars: Death or Financial Burden?

Biosimilars

With so many regulations and so much confusion around biosimilars, it can often feel like patients have to choose between death or financial burden. Work with a CRO that can help you achieve the best biosimilar development program. Watch our latest webinar now to learn more.

Articles

Worldwide Clinical Trials Uses AI with Oncology, Rare Disease Precision

Clinical Research, Oncology

Worldwide Clinical Trials Uses AI with Oncology, Rare Disease Precision

In the following article by North Carolina Biotechnology Center, Dr. Elizabeth Witherspoon, NCBiotech Writer, discusses the strategic partnership between Worldwide and Deep Lens to utilize AI technology and develop a greater oncology focus in order to address rapidly changing trial needs.

Articles

How Engaging Patients in Trial Design Maximizes Orphan Drug Success

Late Phase

How Patient Engagement in Trial Design Maximizes Orphan Drug Success

In the following article by the Journal for Clinical Studies, Worldwide’s Dr. Michael Murphy, Chief Medical and Scientific Officer, and Barbara Zupancic, Senior Director of Patient Recruitment and Retention, discuss the elements of a patient-centric trial design, in addition to high-quality patient engagement and its impact on orphan drug success.

Articles

Worldwide in the News: Morrisville CRO Expands Oncology Unit

Clinical Research, Oncology

Morrisville CRO

In the following Triangle Business Journal article, Worldwide’s Gaurav Sharma, Senior Vice President of Rare Disease and Oncology, discusses the recent expansion to Worldwide’s oncology unit, in addition to new, enhanced capabilities.